These data derived from in vitro studies might reflect in vivo responses of the bone remodeling mechanism; TGFβ1 serum concentrations significantly increased during the early healing period in patients with bone fracture, and they decreased continuously during the late healing period [28]. This evidence concerns the gene TGFB1 and bone fracture.